Conference abstractPublished 28 Mar 2019
Under-representation of vulnerable population in clinical trials impacts negatively on drug development and safety evaluation of new medicine
Managing Director, AlphaBeta Pharma
Subjects
Pharmaceutical SciencesFollow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Assem S. el Baghdady”
